ReviewOncoTargets and therapy2018

Mechanisms of resistance to BRAF and MEK inhibitors and clinical update of US Food and Drug Administration-approved targeted therapy in advanced melanoma.

Sunilkumar Kakadia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.